Early diagnosis and successful treatment of cytomegalovirus peritonitis in children with primary nephrotic syndrome: case series and literature review
暂无分享,去创建一个
Xiaoyun Jiang | Lizhi Chen | Y. Mo | Z. Yue | Liuyi Huang | Hai-ying Lin | Songyang Wen
[1] Na Huang,et al. Peritonitis secondary to hemorrhagic fever with renal syndrome: a case report in GuangZhou China , 2020, BMC infectious diseases.
[2] G. Papanicolaou,et al. CMV Prevention and Treatment in Transplantation: What’s New in 2019 , 2019, Current Infectious Disease Reports.
[3] V. Manchanda,et al. Incidence and risk factors for major infections in hospitalized children with nephrotic syndrome , 2019, Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia.
[4] A. Humar,et al. Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice , 2019, Clinical transplantation.
[5] G. Papanicolaou,et al. A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation , 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[6] P. Niaudet,et al. Acute kidney injury complicating nephrotic syndrome of minimal change disease. , 2018, Kidney international.
[7] R. Goldberg,et al. De novo CMV‐associated collapsing focal segmental glomerulosclerosis in a kidney transplant recipient , 2018, Transplant Infectious Disease.
[8] A. Caliendo,et al. The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation , 2010, Transplantation.
[9] Y. Fukasawa,et al. Cytomegalovirus peritonitis after kidney transplantation diagnosed through histopathological examination , 2017, Transplant infectious disease : an official journal of the Transplantation Society.
[10] T. Fu,et al. Antibody therapies for the prevention and treatment of viral infections , 2017, npj Vaccines.
[11] A. Neumann,et al. Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection , 2017, PLoS pathogens.
[12] P. Jaksch,et al. Maribavir Versus Valganciclovir for Pre-Emptive Treatment of Cytomegalovirus Viremia: A Randomized, Dose-Ranging, Phase 2 Study Among Hematopoietic Stem Cell Transplant and Solid Organ Transplant Recipients , 2017 .
[13] S. Taghavi,et al. Cytomegalovirus Peritonitis Without Gut Perforation But With Concomitant Colitis After a Liver Allograft Transplant. , 2015, Experimental and Clinical Transplantation.
[14] P. Jaksch,et al. Maribavir Versus Valganciclovir for Preemptive Treatment of Cytomegalovirus (CMV) Viremia: A Randomized, Dose-Ranging, Phase 2 Study Among Hematopoietic Stem Cell Transplant (SCT) and Solid Organ Transplant (SOT) Recipients , 2016 .
[15] S. Hirota,et al. Ileum perforation due to cytomegalovirus infection in a patient with adult T‐cell leukemia , 2016, Acute Medicine & Surgery.
[16] D. Selewski,et al. AKI in Children Hospitalized with Nephrotic Syndrome. , 2015, Clinical journal of the American Society of Nephrology : CJASN.
[17] K. Kokko,et al. Cytomegalovirus colitis in a critically ill, dialysis-dependent, acute kidney injury patient without immunosuppressive therapy. , 2015, Clinical Nephrology.
[18] A. Steer,et al. Spontaneous bacterial peritonitis as a presenting feature of nephrotic syndrome , 2013, Journal of paediatrics and child health.
[19] G. Papanicolaou,et al. CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation. , 2013, The New England journal of medicine.
[20] J. Mandal,et al. Clinical spectrum and predictive risk factors of major infections in hospitalized children with nephrotic syndrome , 2013, Indian Pediatrics.
[21] Mikiko Takikita,et al. Ascitic fluid due to type II herpes simplex virus infection: Report of a case with immunocytochemical confirmation , 2013, Diagnostic cytopathology.
[22] J. Cherry,et al. Feigin and Cherry's textbook of pediatric infectious diseases , 2013 .
[23] A. Caliendo,et al. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. , 2013, Transplantation.
[24] L. Danziger-Isakov,et al. Assessment of Cytomegalovirus Hybrid Preventative Strategy in Pediatric Heart Transplant Patients. , 2012, Journal of the Pediatric Infectious Diseases Society.
[25] M. Van Ranst,et al. Coxsackievirus B1 peritonitis in a patient treated with continuous ambulatory peritoneal dialysis: a case report and brief review of the literature. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[26] D. Coen,et al. Stereoselective Phosphorylation of Cyclopropavir by pUL97 and Competitive Inhibition by Maribavir , 2010, Antimicrobial Agents and Chemotherapy.
[27] Angela M Caliendo,et al. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. , 2010, Transplantation.
[28] A. Åsberg,et al. Long‐Term Outcomes of CMV Disease Treatment with Valganciclovir Versus IV Ganciclovir in Solid Organ Transplant Recipients , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[29] D. Lilleri,et al. Prophylaxis followed by preemptive therapy versus preemptive therapy for prevention of human cytomegalovirus disease in pediatric patients undergoing liver transplantation. , 2008, Transplantation.
[30] C. Halma,et al. A cloudy bag and genital ulcers. , 2006, Clinical Nephrology.
[31] S. Wann,et al. Colon perforation with peritonitis in an acquired immunodeficiency syndrome patient due to cytomegalovirus and amoebic colitis. , 2005, Journal of the Formosan Medical Association = Taiwan yi zhi.
[32] A. Schwarz,et al. Cytomegalovirus peritonitis after renal transplantation under induction therapy with alemtuzumab in a young woman previously treated with peritoneal dialysis. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[33] C. Forsmark,et al. Cytomegalovirus peritonitis in a patient with the acquired immunodeficiency syndrome , 1992, Digestive Diseases and Sciences.
[34] P. Senguttuvan,et al. Infections encountered in childhood nephrotics in a pediatric renal unit , 2004 .
[35] B. Rath,et al. Clinical profile of children with nephrotic syndrome not on glucorticoid therapy, but presenting with infection , 2004, Journal of paediatrics and child health.
[36] U. Querfeld,et al. “Sterile peritonitis” caused by varicella in a child on maintenance peritoneal dialysis treatment , 2004, Pediatric nephrology (Berlin, West).
[37] R. Harvey,et al. Potent and Selective Inhibition of Human Cytomegalovirus Replication by 1263W94, a Benzimidazole l-Riboside with a Unique Mode of Action , 2002, Antimicrobial Agents and Chemotherapy.
[38] S. Chou. Cytomegalovirus drug resistance and clinical implications , 2001, Transplant infectious disease : an official journal of the Transplantation Society.
[39] R. Ashley,et al. Herpes simplex virus peritonitis. , 2000, Clinical Infectious Diseases.
[40] T. F. Smith,et al. Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation. , 2000, The Journal of infectious diseases.
[41] T. Babinchak,et al. Herpes simplex peritonitis: case report. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[42] E. Albu,et al. Emergency Surgery for Generalized Peritonitis Caused by Cytomegalovirus Colitis in a Patient with AIDS , 1999, The American surgeon.
[43] B. Gazzard,et al. Summary of the II International Symposium on Cytomegalovirus. , 1998, Antiviral research.
[44] J. Reyes,et al. Comparison of intravenous ganciclovir followed by oral acyclovir with intravenous ganciclovir alone for prevention of cytomegalovirus and Epstein-Barr virus disease after liver transplantation in children. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[45] R. Wyatt,et al. The Role of I and B in Peritonitis Associated with the Nephrotic Syndrome of Childhood , 1993, Pediatric Research.
[46] G. Goldfeld,et al. Detection of CMV-DNA in cells from peritoneal fluid of IPD/CAPD patients by polymerase chain reaction. , 1992, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.
[47] S. Lewis. Recurrent peritonitis: evidence for possible viral etiology. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[48] P. Blake,et al. Cloudy Effluent with Atypical Lymphocytes in a CAPD Patient: Case Report , 1989, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[49] C. Losasso,et al. Coxsackie virus-induced acute pancreatitis in a long-term dialysis patient. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[50] D. Struijk,et al. Viral peritonitis in a continuous ambulatory peritoneal dialysis patient. , 1986, Nephron.
[51] C. Blanc,et al. Impaired IgG synthesis in patients with the nephrotic syndrome. , 1982, Clinical nephrology.
[52] L. Schlesinger,et al. T-cell dysfunction in minimal-change nephrotic syndrome of childhood. , 1982, American journal of diseases of children.
[53] R. Larke,et al. ENTEROVIRAL SYNDROMES IN TORONTO, 1964. , 1965, Canadian Medical Association journal.